샘플 요청 목록

 카트 문의
시장보고서
상품코드
1424093

옥시코돈 의약품 시장, 점유율, 규모, 동향 및 산업 분석 보고서 : 약물 유형별, 제형별, 유통 채널별, 지역별, 부문별 예측(2024-2032년)

Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 옥시코돈 의약품 시장 규모는 2032년까지 82억 9,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

암, 류마티스 관절염, 요통, 섬유근육통 등 만성 통증 질환의 유병률 증가가 옥시코돈 시장 확대의 주요 요인입니다. 또한, 옥시코돈은 다른 약물이 보여주지 못하는 중증 통증 관리에 대한 반응성이 옥시코돈 의약품에 대한 수요를 증가시키고 있습니다. 또한, 이러한 약물의 유망한 결과와 서방형 옥시코돈 의약품과 관련된 장점으로 인해 처방량이 증가하고 있습니다. 또한, 옥시코돈 의약품의 우수한 순응도와 짧은 투여 간격으로 인한 편의성은 향후 몇 년동안 시장 성장의 원동력이 될 것으로 보입니다.

또한, 서방형 캡슐의 등장과 성인의 극심한 통증의 높은 유병률도 시장 성장을 가속하고 있습니다. 또한, 시장 진출기업들이 보유한 특허와 마케팅 및 홍보에 대한 비용 증가가 시장 성장에 기여할 것으로 보입니다. 예를 들어, 코레지움 파마슈티컬의 Xtampza ER은 2036년까지 특허 보호를 받고 있습니다.

또한, 옥시코돈 제제가 다른 오피오이드 제제보다 유망한 결과를 보이고 있다는 점도 시장 성장의 원동력이 되고 있습니다. 또한, 서방형 제제와 같은 약물 전달 시스템의 발전과 함께 새로운 약물의 출현은 옥시코돈 의약품 시장의 성장에 장기적인 기회를 제공할 것으로 보입니다. 수술 후 극심한 통증을 완화하는 옥시코돈의 능력은 수술 증가와 함께 시장 확대를 지원할 것으로 예상됩니다.

옥시코돈이 통증 완화 약물로 널리 받아들여지고 있으며, 수술 후 통증 관리를 위해 옥시코돈에 대한 수요가 증가함에 따라 시장 성장을 가속하는 요인으로 작용하고 있습니다. 또한, 미개척 시장에서의 규제 당국의 승인에 대한 기업들의 높은 관심도 시장 성장에 긍정적인 영향을 미칠 것으로 보입니다. 또한, 운동 부족, 담배 사용, 비만은 만성 통증으로 고통받는 환자 수를 증가시키고 있습니다. 예를 들어, 세계비만연맹의 World Obesity Atlas 2023 Report에 따르면, 전 세계 과체중 또는 비만 인구는 2020년 26억 명에서 40억 명으로 증가할 것으로 예상되고 있습니다. 이러한 비만 인구는 통증 관리 약물을 필요로 하는 사람들이 예측 기간 동안 시장 성장을 주도할 것으로 보입니다.

옥시코돈 의약품 시장 보고서 하이라이트

통증 관리를 개선하고 통증 강도의 편차를 줄일 수 있다는 장점으로 인해 장시간 작용형 부문이 시장을 장악하고 있습니다.

서방형 캡슐의 출현으로 캡슐제 부문은 가장 높은 CAGR로 확대될 것으로 예상됩니다.

병원 분야는 수술 증가와 입원 환자 증가로 인해 가장 큰 시장 점유율을 차지하고 있습니다.

북미는 옥시코돈 처방량이 많고 만성 통증 질환이 증가함에 따라 시장을 독점하고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 옥시코돈 의약품 시장 인사이트

  • 옥시코돈 의약품 시장 - 유통 채널 현황
  • 옥시코돈 의약품 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTEL 분석
  • 옥시코돈 의약품 시장 유통 채널 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 옥시코돈 의약품 시장, 약제 유형별

  • 주요 조사 결과
  • 서론
  • 단시간 작용형
  • 장시간 작용형

제6장 세계의 옥시코돈 의약품 시장, 제형별

  • 주요 조사 결과
  • 서론
  • 정제
  • 캡슐
  • 주사

제7장 세계의 옥시코돈 의약품 시장, 유통 채널별

  • 주요 조사 결과
  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 옥시코돈 의약품 시장, 지역별

  • 주요 조사 결과
  • 서론
    • 옥시코돈 의약품 시장 평가, 지역별, 2019-2032년
  • 옥시코돈 의약품 시장 - 북미
    • 북미 : 옥시코돈 의약품 시장, 약제 유형별, 2019-2032년
    • 북미 : 옥시코돈 의약품 시장, 유통 채널별, 2019-2032년
    • 북미 : 옥시코돈 의약품 시장, 제형별, 2019-2032년
    • 옥시코돈 의약품 시장 - 미국
    • 옥시코돈 의약품 시장 - 캐나다
  • 옥시코돈 의약품 시장 - 유럽
    • 유럽 : 옥시코돈 의약품 시장, 약제 유형별, 2019-2032년
    • 유럽 : 옥시코돈 의약품 시장, 유통 채널별, 2019-2032
    • 유럽 : 옥시코돈 의약품 시장, 제형별, 2019-2032년
    • 옥시코돈 의약품 시장 - 영국
    • 옥시코돈 의약품 시장 - 프랑스
    • 옥시코돈 의약품 시장 - 독일
    • 옥시코돈 의약품 시장 - 이탈리아
    • 옥시코돈 의약품 시장 - 스페인
    • 옥시코돈 의약품 시장 - 네덜란드
    • 옥시코돈 의약품 시장 - 러시아
  • 옥시코돈 의약품 시장 - 아시아태평양
    • 아시아태평양 : 옥시코돈 의약품 시장, 약제 유형별, 2019-2032년
    • 아시아태평양 : 옥시코돈 의약품 시장, 유통 채널별, 2019-2032년
    • 아시아태평양 : 옥시코돈 의약품 시장, 제형별, 2019-2032년
    • 옥시코돈 의약품 시장 - 중국
    • 옥시코돈 의약품 시장 - 인도
    • 옥시코돈 의약품 시장 - 말레이시아
    • 옥시코돈 의약품 시장 - 일본
    • 옥시코돈 의약품 시장 - 인도네시아
    • 옥시코돈 의약품 시장 - 한국
  • 옥시코돈 의약품 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 옥시코돈 의약품 시장, 약제 유형별, 2019-2032년
    • 중동 및 아프리카 : 옥시코돈 의약품 시장, 유통 채널별, 2019-2032
    • 중동 및 아프리카 : 옥시코돈 의약품 시장, 제형별, 2019-2032년
    • 옥시코돈 의약품 시장 - 사우디아라비아
    • 옥시코돈 의약품 시장 - 아랍에미리트(UAE)
    • 옥시코돈 의약품 시장 - 이스라엘
    • 옥시코돈 의약품 시장 - 남아프리카
  • 옥시코돈 의약품 시장 - 라틴아메리카
    • 라틴아메리카 : 옥시코돈 의약품 시장, 약제 유형별, 2019-2032년
    • 라틴아메리카 : 옥시코돈 의약품 시장, 유통 채널별, 2019-2032
    • 라틴아메리카 : 옥시코돈 의약품 시장, 제형별, 2019-2032년
    • 옥시코돈 의약품 시장 - 멕시코
    • 옥시코돈 의약품 시장 - 브라질
    • 옥시코돈 의약품 시장 - 아르헨티나

제9장 경쟁 구도

  • 확장 및 인수 분석
    • 확장
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Acura Pharmaceuticals(U.S.)
  • Alvogen(U.S.)
  • Amneal Pharmaceuticals LLC.(U.S.)
  • Ascent Pharmaceuticals, Inc.(U.S.)
  • Collegium Pharmaceutical(U.S.)
  • Endo International plc(Ireland)
  • Epic Pharma, LLC.(U.S.)
  • Mallinckrodt(Ireland)
  • Mundipharma International(UK)
  • Pfizer Inc.(U.S.)
  • Protega Pharmaceuticals Inc.(U.S.)
  • Rhodes Pharmaceuticals L.P.(U.S.)
  • Sun Pharmaceutical Industries Ltd.(India)
LSH 24.02.27

The global oxycodone drugs market size is expected to reach USD 8.29 billion by 2032, according to a new study by Polaris Market Research. The report "Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising incidence of chronic pain disease such as cancer, rheumatoid arthritis, lower back pain, and fibromyalgia is the primary contributor for the oxycodone market expansion. Moreover, the unresponsiveness shown by other medications for the treatment of severe pain management has increased the demand for oxycodone drugs. Furthermore, promising results of these drugs and benefits associated with the extended release oxycodone drugs has increased its prescription volumes. Additionally, better compliance and convenience of less-frequent dosage intervals offered by oxycodone drugs will fuel the market growth in the coming years.

The advent of extended-release capsules coupled with the high prevalence of severe pain among adults are also propelling the market growth. Moreover, the patents owned by market players coupled with their increasing expenses on marketing and promotion will contribute to the market growth. For instance, Collegium Pharmaceutical's Xtampza ER has patent protection until 2036.

The promising results shown by the oxycodone drugs over other opioid medications is also driving the market growth. Moreover, the advent of new drugs with advancements in drug delivery systems such as extended-release formulations will provide long-term opportunity for the oxycodone drugs market growth. The ability of oxycodone to lower the severe pain after surgery coupled with an increasing number of surgical procedures are expected to support the market expansion.

The widespread acceptance of oxycodone drugs as a pain-relieving medication and growing need for oxycodone for the pain management after surgeries are the factors propelling the market growth. Moreover, the strong focus of companies on the regulatory approvals in untapped markets will positively influence the market growth. Furthermore, lack of physical activities, tobacco usage, and obesity are increasing the number of patients suffering from chronic pain. For instance, according to the World Obesity Atlas 2023 Report by the World Obesity Federation, the number of people with overweight or obesity worldwide is expected to increase to 4.0 billion, from 2.6 billion in 2020. Such obese people requiring pain management medications will drive the market growth during the forecast period.

Oxycodone Drugs Market Report Highlights

The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.

The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.

Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.

North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.

The market players include Collegium Pharmaceutical, Mundipharma International, Sun Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt.

Polaris Market Research has segmented the oxycodone drugs market report based on drug type, dosage form, distribution channel, and region:

Oxycodone Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Short-acting
  • Long-acting

Oxycodone Drugs, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablet
  • Capsule
  • Injection

Oxycodone Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Oxycodone Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oxycodone Drugs Market Insights

  • 4.1. Oxycodone Drugs Market - Distribution Channel Snapshot
  • 4.2. Oxycodone Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of chronic pain is expected to support the oxycodone market expansion
      • 4.2.1.2. Increasing expenses for oxycodone drugs will provide a long-term opportunity for the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Several risks of oxycodone coupled with strict regulations is expected to hamper the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Oxycodone Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oxycodone Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Short-acting
    • 5.3.1. Global Oxycodone Drugs Market, by Short-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Long-acting
    • 5.4.1. Global Oxycodone Drugs Market, by Long-acting, by Region, 2019-2032 (USD Billion)

6. Global Oxycodone Drugs Market, by Dosage Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 6.3. Tablet
    • 6.3.1. Global Oxycodone Drugs Market, by Tablet, by Region, 2019-2032 (USD Billion)
  • 6.4. Capsule
    • 6.4.1. Global Oxycodone Drugs Market, by Capsule, by Region, 2019-2032 (USD Billion)
  • 6.5. Injection
    • 6.5.1. Global Oxycodone Drugs Market, by Injection, by Region, 2019-2032 (USD Billion)

7. Global Oxycodone Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Oxycodone Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Oxycodone Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Oxycodone Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Oxycodone Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Oxycodone Drugs Market - North America
    • 8.3.1. North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.4. Oxycodone Drugs Market - U.S.
      • 8.3.4.1. U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.5. Oxycodone Drugs Market - Canada
      • 8.3.5.1. Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.4. Oxycodone Drugs Market - Europe
    • 8.4.1. Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.4. Oxycodone Drugs Market - UK
      • 8.4.4.1. UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.5. Oxycodone Drugs Market - France
      • 8.4.5.1. France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.6. Oxycodone Drugs Market - Germany
      • 8.4.6.1. Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.7. Oxycodone Drugs Market - Italy
      • 8.4.7.1. Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.8. Oxycodone Drugs Market - Spain
      • 8.4.8.1. Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.9. Oxycodone Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.10. Oxycodone Drugs Market - Russia
      • 8.4.10.1. Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.5. Oxycodone Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.4. Oxycodone Drugs Market - China
      • 8.5.4.1. China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.5. Oxycodone Drugs Market - India
      • 8.5.5.1. India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.6. Oxycodone Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.7. Oxycodone Drugs Market - Japan
      • 8.5.7.1. Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.8. Oxycodone Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.9. Oxycodone Drugs Market - South Korea
      • 8.5.9.1. South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.6. Oxycodone Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.4. Oxycodone Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.5. Oxycodone Drugs Market - UAE
      • 8.6.5.1. UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.6. Oxycodone Drugs Market - Israel
      • 8.6.6.1. Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.7. Oxycodone Drugs Market - South Africa
      • 8.6.7.1. South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.7. Oxycodone Drugs Market - Latin America
    • 8.7.1. Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.4. Oxycodone Drugs Market - Mexico
      • 8.7.4.1. Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.5. Oxycodone Drugs Market - Brazil
      • 8.7.5.1. Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.6. Oxycodone Drugs Market - Argentina
      • 8.7.6.1. Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Acura Pharmaceuticals (U.S.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2.Alvogen (U.S.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amneal Pharmaceuticals LLC. (U.S.)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ascent Pharmaceuticals, Inc. (U.S.)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Collegium Pharmaceutical (U.S.)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Endo International plc (Ireland)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Epic Pharma, LLC. (U.S.)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mallinckrodt (Ireland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mundipharma International (UK)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer Inc. (U.S.)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Protega Pharmaceuticals Inc. (U.S.)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Rhodes Pharmaceuticals L.P. (U.S.)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd. (India)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제